Cargando…
Methylprednisolone: Worsening of SARS-CoV-2 infection during off-label treatment: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442179/ http://dx.doi.org/10.1007/s40278-020-82455-2 |
Ejemplares similares
-
Methylprednisolone: Worsening hyperglycaemia and off-label use: case report
Publicado: (2021) -
Immune-globulin/methylprednisolone/tocilizumab: Lack of response following off-label use in SARS-CoV-2 infection: case report
Publicado: (2021) -
Convalescent-anti-SARS-CoV-2-plasma/enoxaparin-sodium/methylprednisolone: Various toxicities and off label use: case report
Publicado: (2021) -
Remdesivir/methylprednisolone/convalescent-anti-SARS-CoV-2-plasma: Elevated aminotransferase levels and off-label use: case report
Publicado: (2021) -
Methylprednisolone: Strongyloidiasis following off-label treatment: case report
Publicado: (2022)